PedAM
Pediatric Disease Annotations & Medicines
| Disease | irritable bowel syndrome |
| Symptom | C0000737|abdominal pain |
| Sentences | 16 |
| PubMedID- 22937879 | Background: mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (ibs). |
| PubMedID- 22500715 | Objective: acupuncture has been clinically proved to be effective in treating abdominal pain in patients with irritable bowel syndrome (ibs). |
| PubMedID- 22493949 | Objectives: the objective of this case report is to describe the use of transverse tripolar dorsal column stimulation in a patient with a history of irritable bowel syndrome (ibs) associated with abdominal pain resistant to conservative treatments. |
| PubMedID- 26290286 | Background: consensus on standard methods to assess chronic abdominal pain in patients with irritable bowel syndrome (ibs) is currently lacking. |
| PubMedID- 25488056 | Thus, saccharomyces cerevisiae may be a new promising candidate for improving abdominal pain in subjects with irritable bowel syndrome. |
| PubMedID- 26486119 | We present one such case of early closure in a 32-year-old male with recurrent abdominal pain who was diagnosed with irritable bowel syndrome (ibs). |
| PubMedID- 22738315 | Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome. |
| PubMedID- 23583433 | Background & aims: simultaneous agonism of the mu-opioid receptor and antagonism of the delta-opioid receptor can reduce abdominal pain and diarrhea in patients with irritable bowel syndrome with diarrhea (ibs-d) without constipating side effects. |
| PubMedID- 20371236 | Trimebutine maleate, which modulates the calcium and potassium channels, relieves abdominal pain in patients with irritable bowel syndrome. |
| PubMedID- 25581334 | Symptom-association probability between meal ingestion and abdominal pain in patients with irritable bowel syndrome. |
| PubMedID- 25206515 | Chronic visceral hypersensitivity has been shown to be the main pathophysiological mechanism underlying abdominal pain in patients with irritable bowel syndrome. |
| PubMedID- 26270949 | A review and several meta-analyses of randomised, double blind, placebo-controlled trials in adults have demonstrated that pmo is effective in reducing abdominal pain in patients with irritable bowel syndrome (ibs).13–7 however, in children with ibs, there is a dearth of information restricted to a single small (n=42), double blind, placebo-controlled trial.7 nonetheless, the use of pmo as an adjunctive measure to treat children with ibs continues to evolve in clinical practice despite the lack of any information pertaining to the impact of age and/or disease state on its pharmacodynamics (pds) or pharmacokinetics (pks). |
| PubMedID- 24282804 | (2004) reported the relation of psychological factors with the etiology of irritable bowel syndrome often associated with abdominal pain. |
| PubMedID- 21481494 | Recurrent abdominal pain in a patient with irritable bowel syndrome. |
| PubMedID- 19800336 | Background & aims: chronic stress exacerbates or causes relapse of symptoms such as abdominal pain and cramping in patients with irritable bowel syndrome. |
| PubMedID- 26279684 | For example, l. plantarum 299v eases abdominal pains in patients with irritable bowel syndrome, an illness characterized by overactive inflammatory responses in the gut 6. |
Page: 1